Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00710333 · ClinicalTrials.gov registry record · Phase 1

Safety of Juvista When Administered Following Excision of Ear Lobe Keloids

A Phase 1 study of Keloid, sponsored by Renovo.

Completed
Registry status
Phase 1
Development phase
10
Enrollment target
1
Study location

NCT00710333 is a Phase 1 study of Keloid that has completed, run by Renovo. The registered enrollment target is 10 participants, below the 2,143-participant average among 8 other Keloid trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00710333, a Phase 1 study of Keloid, has completed, sponsored by Renovo.

COMPLETED
Registry status
Phase 1
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This trial will assess the safety and efficacy of 500ng Juvista per linear cm of wound margin administered by intradermal injection following the excision of keloid scars on the ear lobe. Ear lobe keloids commonly occur after ear piercing and can be particularly distressing for patients as they are very difficult to conceal and are usually bilateral. As the recurrence rate and growth rate of keloids can vary significantly between individuals, trial subjects will have bilateral ear lobe keloids and will act as their own control. One ear lobe will be treated with Juvista following keloid excision and one with placebo.

Conditions Studied

Keloid

Interventions

  • DRUG placebo
  • DRUG Avotermin

Study Locations (1)

Missouri

  • Body Aesthetic Plastic Surgery and Skincare Center - St Louis

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2008-07
Est. Completion 2009-12
Phase Phase 1

Sponsor

Renovo

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00710333

The ClinicalTrials.gov registry entry for NCT00710333 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,143-participant average among 8 other Keloid trials with a reported enrollment target (100% lower). The listed sponsor is Renovo, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Keloid appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT00710333 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT00710333 about?

NCT00710333 is a clinical study titled "Safety of Juvista When Administered Following Excision of Ear Lobe Keloids". This trial will assess the safety and efficacy of 500ng Juvista per linear cm of wound margin administered by intradermal injection following the excision of keloid scars on the ear lobe. Ear lobe keloids commonly occur after ear piercing and can be particularly distressing for patients as they are ...

What is the current status of trial NCT00710333?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2008-07. Estimated completion is 2009-12.

What conditions does trial NCT00710333 study?

This clinical trial studies the following conditions: Keloid.

What interventions are being tested in trial NCT00710333?

The interventions under investigation include: placebo (DRUG), Avotermin (DRUG).

Who is sponsoring clinical trial NCT00710333?

This trial is sponsored by Renovo, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00710333 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Keloid

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Keloid

All registered trials for this condition

Missouri

All trials with a study site in Missouri

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.